Intervention

OPC-34712 + ADT

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common conditions5

Lead sponsors shown1

Clinical trials

2 shown

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)NCT01360645 · 2011-07-01

COMPLETED

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)NCT01360632 · 2011-06-01

COMPLETED

Common conditions

Depression2 Depressive Disorder2 Depressive Disorder, Major2 Mental Disorders2 Mood Disorders2

Leading sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc. 2

Trial status mix

COMPLETED2

Phase mix

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.